Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för umeclidinium. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2014-07-01

Population pharmacokinetics of inhaled umeclidinium and vilanterol in patients with chronic obstructive pulmonary disease.

Goyal N, Beerahee M, Kalberg C, Church A, Kilbride S, Mehta R.

Clin Pharmacokinet · research support, non-u.s. gov't; journal article · DOI 10.1007/s40262-014-0143-4

Bibliografisk träff 2014-06-24

Dose response of umeclidinium administered once or twice daily in patients with COPD: a pooled analysis of two randomized, double-blind, placebo-controlled studies.

Donohue JF, Kalberg C, Shah P, Beerahee M, Mehta R, Gunawan R, Church A.

J Clin Pharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1002/jcph.340

Bibliografisk träff 2014-06-17

Effects of moderate hepatic impairment on the pharmacokinetic properties and tolerability of umeclidinium and vilanterol in inhalational umeclidinium monotherapy and umeclidinium/vilanterol combination therapy: an open-label, nonrandomized study.

Mehta R, Hardes K, Kelleher D, Preece A, Tombs L, Brealey N.

Clin Ther · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2014.05.002

Bibliografisk träff 2014-05-01

Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study.

Celli B, Crater G, Kilbride S, Mehta R, Tabberer M, Kalberg CJ, Church A.

Chest · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1378/chest.13-1579

Bibliografisk träff 2014-03-01

Umeclidinium/Vilanterol: first global approval.

Scott LJ, Hair P.

Drugs · journal article · DOI 10.1007/s40265-014-0186-8

Bibliografisk träff 2014-03-01

Umeclidinium/vilanterol fixed-dose combination for COPD.

Gras J.

Drugs Today (Barc) · journal article · DOI 10.1358/dot.2014.50.3.2122119

Bibliografisk träff 2014-02-01

Umeclidinium-vilanterol inhaler approved for COPD.

Traynor K.

Am J Health Syst Pharm · news · DOI 10.2146/news140009

Bibliografisk träff 2014-01-06

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study.

Church A, Beerahee M, Brooks J, Mehta R, Shah P.

BMC Pulm Med · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1186/1471-2466-14-2

Bibliografisk träff 2013-08-15

Umeclidinium in patients with COPD: a randomised, placebo-controlled study.

Trivedi R, Richard N, Mehta R, Church A.

Eur Respir J · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1183/09031936.00033213

Bibliografisk träff 2013-03-27

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study.

Mehta R, Kelleher D, Preece A, Hughes S, Crater G.

Int J Chron Obstruct Pulmon Dis · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.2147/copd.s40859

Bibliografisk träff 2012-12-28

Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: two randomised studies.

Tal-Singer R, Cahn A, Mehta R, Preece A, Crater G, Kelleher D, Pouliquen IJ.

Eur J Pharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.ejphar.2012.12.019

Bibliografisk träff 2012-09-28

Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients.

Decramer M, Maltais F, Feldman G, Brooks J, Harris S, Mehta R, Crater G.

Respir Physiol Neurobiol · multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.resp.2012.08.022